We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds

News   Jun 19, 2013

 
Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds
 
 
 

RELATED ARTICLES

New Hope for Aggressive Breast Cancer: Diabetes Drug Creates Treatment “Sweet Spot”

News

New research funded by Breast Cancer Now has shown that a drug commonly used to treat Type 2 diabetes could make breast cancer cells susceptible to new treatments.

READ MORE

Widely Available Antibiotics Could Be Used to Treat “Superbug” MRSA

News

Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.

READ MORE

Study Suggests Commonly-prescribed Drugs Could Increase Risk of Dementia

News

New research suggests that regular use of certain types of commonly-prescribed drugs used to treat bladder conditions, Parkinson’s disease and depression, could significantly increase the risk of dementia in later life.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE